IO Biotech Announces Board and Executive Changes
Ticker: IOBT · Form: 8-K · Filed: Jun 20, 2025 · CIK: 1865494
| Field | Detail |
|---|---|
| Company | Io Biotech, Inc. (IOBT) |
| Form Type | 8-K |
| Filed Date | Jun 20, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: management-change, board-of-directors, executive-compensation
TL;DR
IO Biotech reshuffled its board and exec team, effective June 19th.
AI Summary
IO Biotech, Inc. announced on June 19, 2025, changes in its board of directors and executive compensation arrangements. The filing details the departure of certain officers and directors, the election of new directors, and updates to compensatory arrangements for key personnel. These changes are effective as of June 19, 2025.
Why It Matters
Changes in a company's board and executive team can signal shifts in strategy, operational focus, or financial health, impacting investor confidence and future performance.
Risk Assessment
Risk Level: medium — Board and executive changes can indicate internal restructuring or strategic shifts that may carry inherent risks.
Key Players & Entities
- IO Biotech, Inc. (company) — Registrant
- June 19, 2025 (date) — Date of earliest event reported
FAQ
What specific items are being reported in this Form 8-K?
This Form 8-K reports on the departure of directors or certain officers, the election of directors, the appointment of certain officers, and compensatory arrangements of certain officers.
What is the exact name of the Registrant?
The exact name of the Registrant is IO BIOTECH, INC.
In which jurisdiction was IO Biotech, Inc. incorporated?
IO Biotech, Inc. was incorporated in Delaware.
What is the principal executive office address of IO Biotech, Inc.?
The principal executive office address is Ole Maaløes Vej 3, DK-2200 Copenhagen N, Denmark.
What is the telephone number for IO Biotech, Inc.?
The Registrant's telephone number, including area code, is +45 7070 2980.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 20, 2025 regarding IO Biotech, Inc. (IOBT).